罗氏、科伦博泰、加科思等热议创新药临床试验“30日通道”

医药经济报
30 Jun

近日,国家药监局发布《关于优化创新药临床试验审评审批有关事项的公告(征求意见稿)》(以下简称《征求意见稿》),提出对符合要求的创新药临床试验申请将在30个工作日内完成审评审批(以下简称“30日通道”,征求意见截至7月16日。当前,全球医药产业链面临重构,中国正加速成为全球创新策源地。临床试验审批提速将明显缩短新药研发的起跑时间,那么,谁能驶入这条快车道?审批提速的政策东风还将带来哪些深远影响?《...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10